Ted M. Ross, PhD, University of Georgia

Ted M. Ross, PhD
Ted M. Ross, PhD

Dr. Ross's research focuses on designing, developing and testing vaccines for viral diseases that are often at the interface of zoonotic and human interface, such as influenza, dengue, chikungunya, respiratory syncytial virus and HIV. Dr. Ross' laboratory developed computationally-optimized broadly reactive antigen (COBRA) technology for the universal, rational design of vaccine candidates for influenza viruses. He and his laboratory have developed DNA, recombinant protein and virus-like particle (VLP) vaccines for pandemic and seasonal influenza pre-clinical and clinical research trials.

Products

References

  1. Kirchenbaum GA, Ross TM. Generation of Monoclonal Antibodies against Immunoglobulin Proteins of the Domestic Ferret (Mustela putorius furo). J Immunol Res. 2017;2017:5874572.
  2. Kirchenbaum GA, Allen JD, Layman TS, Sautto GA, Ross TM. Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin. J Immunol. 2017 Oct 27. pii: ji1701174.
  3. Sautto GA, Kirchenbaum GA, Abreu RB, Ecker JW, Pierce SR, Kleanthous H, Ross TM. A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin. J Immunol. 2020 Jan 15;204(2):375-385. doi: 10.4049/jimmunol.1900379. Epub 2019 Dec 6. PMID: 31811019.